Veterinary Medicines

Biocan LR injekčná suspenzia

Authorised
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated
  • Rabies virus, Inactivated
Download as PDF

Product identification

Medicine name:
Biocan LR injekčná suspenzia
Active substance:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated
  • Rabies virus, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1010, Inactivated
    10.00
    million organisms
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1008, Inactivated
    10.00
    million organisms
    /
    1.00
    millilitre(s)
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1009, Inactivated
    10.00
    million organisms
    /
    1.00
    millilitre(s)
  • Rabies virus, Inactivated
    2.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/085/04-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 28/12/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."